Zobrazeno 1 - 6
of 6
pro vyhledávání: '"De Cecco, Loris"'
Autor:
Cavalieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Bruno E; Nutrition Research and Metabolomics, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Serafini MS; Integrated Biology of Rare Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lenoci D; Integrated Biology of Rare Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Canevari S; Retired, Milan, Italy., Lopez-Perez L; Universidad Politecnica de Madrid-Life Supporting Technologies Research Group, ETSIT, Madrid, Spain., Hernandez L; Universidad Politecnica de Madrid-Life Supporting Technologies Research Group, ETSIT, Madrid, Spain., Mariani L; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Miceli R; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Gavazzi C; Clinical Nutrition Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pasanisi P; Nutrition Research and Metabolomics, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rosso E; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Computer Science, University of Torino, Torino, Italy., Cordero F; Department of Computer Science, University of Torino, Torino, Italy., Bossi P; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Golusinski W; Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland., Dietz A; Department of Otolaryngology, Head and Neck Surgery, Universitätsklinikum, Leipzig, Germany., Strojan P; Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Fuereder T; Department of Medicine I, Medical University of Vienna, Vienna, Austria., De Cecco L; Integrated Biology of Rare Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jan 04; Vol. 13, pp. 1321174. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2023).
Autor:
Minna E; Pathology Unit 2, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Devecchi A; Pathology Unit 2, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pistore F; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Paolini B; Pathology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mauro G; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Penso DA; Pathology Unit 2, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pagliardini S; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Busico A; Pathology Unit 2, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pruneri G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Borrello MG; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sensi M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Greco A; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 05; Vol. 14, pp. 1267499. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023).
Autor:
Cumbo C; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Orsini P; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Anelli L; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Zagaria A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Iannò MF; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Molecular Mechanisms Unit, Department of Research Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Minervini CF; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Coccaro N; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Tota G; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Parciante E; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Conserva MR; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Redavid I; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Tarantini F; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Minervini A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Carluccio P; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., De Grassi A; Laboratory of Biochemistry, Molecular and Computational Biology, Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Pierri CL; Laboratory of Biochemistry, Molecular and Computational Biology, Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Specchia G; School of Medicine, University of Bari 'Aldo Moro', Bari, Italy., Musto P; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy., Albano F; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari 'Aldo Moro', Bari, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jun 28; Vol. 13, pp. 1205220. Date of Electronic Publication: 2023 Jun 28 (Print Publication: 2023).
Autor:
Gargiuli C; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mariancini A; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Iannò MF; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Micali A; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mancinelli E; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Boeri M; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sozzi G; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sensi M; Platform of Integrated Biology Unit, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jul 19; Vol. 12, pp. 911613. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).
Autor:
Locati LD; Head and Neck Cancer Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Serafini MS; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Carenzo A; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Canevari S; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Perrone F; Pathology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Orlandi E; Radiation Oncology Clinical Department, National Center of Oncological Hadrontherapy, Pavia, Italy., Delbue S; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Cavalieri S; Head and Neck Cancer Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Berzeri G; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy., Pichiecchio A; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; Advanced Imaging and Radiomics Center, Neuroradiology Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy., Licitra LF; Head and Neck Cancer Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.; Department of Hematology and Oncology, University of Milan, Milan, Italy., Marchioni E; Neuroncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy., De Cecco L; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jan 10; Vol. 11, pp. 799453. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2021).
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.
Autor:
Caleca L; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Catucci I; Genome Diagnostics Program, IFOM the FIRC Institute of Molecular Oncology, Milan, Italy., Figlioli G; Genome Diagnostics Program, IFOM the FIRC Institute of Molecular Oncology, Milan, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pesaran T; Ambry Genetics, Department of Clinical Diagnostics, Aliso Viejo, CA, United States., Ward M; Cancer Outreach and Risk Assessment, Via Christi Hospitals, Wichita, KS, United States., Volorio S; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.; Cogentech Cancer Genetics Test Laboratory, Milan, Italy., Falanga A; Department of Immunohematology and Transfusion Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Marchetti M; Cogentech Cancer Genetics Test Laboratory, Milan, Italy., Iascone M; USSD Laboratorio Genetica Medica, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Tondini C; Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Zambelli A; Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Peterlongo P; Genome Diagnostics Program, IFOM the FIRC Institute of Molecular Oncology, Milan, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2018 Oct 25; Vol. 8, pp. 480. Date of Electronic Publication: 2018 Oct 25 (Print Publication: 2018).